{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:06:04Z","timestamp":1792602364409,"version":"4.5.0"},"reference-count":160,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Nowadays, a pathological increase in the permeability of the intestinal barrier (the so-called leaky gut) is increasingly being diagnosed. This condition can be caused by various factors, mainly from the external environment. Damage to the intestinal barrier entails a number of adverse phenomena: dysbiosis, translocation of microorganisms deep into the intestinal tissue, immune response, development of chronic inflammation. These phenomena can ultimately lead to a vicious cycle that promotes the development of inflammation and further damage to the barrier. Activated immune cells in mucosal tissues with broken barriers can migrate to other organs and negatively affect their functioning. Damaged intestinal barrier can facilitate the development of local diseases such as irritable bowel disease, inflammatory bowel disease or celiac disease, but also the development of systemic inflammatory diseases such as rheumatoid arthritis, ankylosing spondylitis, hepatitis, and lupus erythematosus, neurodegenerative or psychiatric conditions, or metabolic diseases such as diabetes or obesity. However, it must be emphasized that the causal links between a leaky gut barrier and the onset of certain diseases often remain unclear and require in-depth research. In light of recent research, it becomes crucial to prevent damage to the intestinal barrier, as well as to develop therapies for the barrier when it is damaged. This paper presents the current state of knowledge on the causes, health consequences and attempts to treat excessive permeability of the intestinal barrier.<\/jats:p>","DOI":"10.1007\/s10238-024-01496-9","type":"journal-article","created":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T07:01:44Z","timestamp":1727506904000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":97,"title":["Intestinal permeability disturbances: causes, diseases and therapy"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5388-6517","authenticated-orcid":false,"given":"Barbara","family":"Macura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3818-8972","authenticated-orcid":false,"given":"Aneta","family":"Kiecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0388-2382","authenticated-orcid":false,"given":"Marian","family":"Szczepanik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,28]]},"reference":[{"issue":"11","key":"1496_CR1","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/s41577-021-00538-7","volume":"21","author":"CA Akdis","year":"2021","unstructured":"Akdis CA. Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions? Nat Rev Immunol. 2021;21(11):739\u201351. https:\/\/doi.org\/10.1038\/s41577-021-00538-7.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"1496_CR2","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1111\/all.15240","volume":"77","author":"Z Celebi Sozener","year":"2022","unstructured":"Celebi Sozener Z, Ozdel Ozturk B, Cerci P, Turk M, Gorgulu Akin B, Akdis M, Altiner S, Ozbey U, Ogulur I, Mitamura Y, Yilmaz I, Nadeau K, Ozdemir C, Mungan D, Akdis CA. Epithelial barrier hypothesis: effect of the external exposome on the microbiome and epithelial barriers in allergic disease. Allergy. 2022;77(5):1418\u201349. https:\/\/doi.org\/10.1111\/all.15240.","journal-title":"Allergy"},{"issue":"3","key":"1496_CR3","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.jaci.2018.01.016","volume":"141","author":"L Cecchi","year":"2018","unstructured":"Cecchi L, D\u2019Amato G, Annesi-Maesano I. External exposome and allergic respiratory and skin diseases. J Allergy Clin Immunol. 2018;141(3):846\u201357. https:\/\/doi.org\/10.1016\/j.jaci.2018.01.016.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"1496_CR4","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/j.jaci.2020.04.024","volume":"145","author":"ZC S\u00f6zener","year":"2020","unstructured":"S\u00f6zener ZC, Cevhertas L, Nadeau K, Akdis M, Akdis CA. Environmental factors in epithelial barrier dysfunction. J Allergy Clin Immunol. 2020;145(6):1517\u201328. https:\/\/doi.org\/10.1016\/j.jaci.2020.04.024.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"1496_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaci.2017.05.010","volume":"140","author":"AJ Burbank","year":"2017","unstructured":"Burbank AJ, Sood AK, Kesic MJ, Peden DB, Hernandez ML. Environmental determinants of allergy and asthma in early life. J Allergy Clin Immunol. 2017;140(1):1\u201312. https:\/\/doi.org\/10.1016\/j.jaci.2017.05.010.","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"1496_CR6","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1111\/all.13812","volume":"74","author":"H Sbihi","year":"2019","unstructured":"Sbihi H, Boutin RC, Cutler C, Suen M, Finlay BB, Turvey SE. Thinking bigger: how early-life environmental exposures shape the gut microbiome and influence the development of asthma and allergic disease. Allergy. 2019;74(11):2103\u201315. https:\/\/doi.org\/10.1111\/all.13812.","journal-title":"Allergy"},{"issue":"1","key":"1496_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jaci.2009.05.038","volume":"124","author":"KR Groschwitz","year":"2009","unstructured":"Groschwitz KR, Hogan SP. Intestinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol. 2009;124(1):3\u201320. https:\/\/doi.org\/10.1016\/j.jaci.2009.05.038.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"1496_CR8","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3390\/molecules28020619","volume":"28","author":"RS Aleman","year":"2023","unstructured":"Aleman RS, Moncada M, Aryana KJ. Leaky gut and the ingredients that help treat it: a review. Molecules. 2023;28(2):619. https:\/\/doi.org\/10.3390\/molecules28020619.","journal-title":"Molecules"},{"issue":"4","key":"1496_CR9","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1002\/eji.202048876","volume":"51","author":"C Brandl","year":"2021","unstructured":"Brandl C, Bucci L, Schett G, Zaiss MM. Crossing the barriers: Revisiting the gut feeling in rheumatoid arthritis. Eur J Immunol. 2021;51(4):798\u2013810. https:\/\/doi.org\/10.1002\/eji.202048876.","journal-title":"Eur J Immunol"},{"issue":"Suppl 4","key":"1496_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/jgh.12294","volume":"28","author":"BS Ramakrishna","year":"2013","unstructured":"Ramakrishna BS. Role of the gut microbiota in human nutrition and metabolism. J Gastroenterol Hepatol. 2013;28(Suppl 4):9\u201317. https:\/\/doi.org\/10.1111\/jgh.12294.","journal-title":"J Gastroenterol Hepatol"},{"issue":"7610","key":"1496_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nature18849","volume":"535","author":"AJ B\u00e4umler","year":"2016","unstructured":"B\u00e4umler AJ, Sperandio V. Interactions between the microbiota and pathogenic bacteria in the gut. Nature. 2016;535(7610):85\u201393. https:\/\/doi.org\/10.1038\/nature18849.","journal-title":"Nature"},{"issue":"10","key":"1496_CR12","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1002\/emmm.201201773","volume":"5","author":"MJ Ostaff","year":"2013","unstructured":"Ostaff MJ, Stange EF, Wehkamp J. Antimicrobial peptides and gut microbiota in homeostasis and pathology. EMBO Mol Med. 2013;5(10):1465\u201383. https:\/\/doi.org\/10.1002\/emmm.201201773.","journal-title":"EMBO Mol Med"},{"issue":"1","key":"1496_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.mib.2011.11.002","volume":"15","author":"GC Hansson","year":"2012","unstructured":"Hansson GC. Role of mucus layers in gut infection and inflammation. Curr Opin Microbiol. 2012;15(1):57\u201362. https:\/\/doi.org\/10.1016\/j.mib.2011.11.002.","journal-title":"Curr Opin Microbiol"},{"issue":"17","key":"1496_CR14","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1007\/s00018-012-0984-7","volume":"69","author":"F Gerbe","year":"2012","unstructured":"Gerbe F, Legraverend C, Jay P. The intestinal epithelium tuft cells: specification and function. Cell Mol Life Sci. 2012;69(17):2907\u201317. https:\/\/doi.org\/10.1007\/s00018-012-0984-7.","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"1496_CR15","doi-asserted-by":"publisher","first-page":"a002584","DOI":"10.1101\/cshperspect.a002584","volume":"1","author":"JM Anderson","year":"2009","unstructured":"Anderson JM, Van Itallie CM. Physiology and function of the tight junction. Cold Spring Harb Perspect Biol. 2009;1(2):a002584. https:\/\/doi.org\/10.1101\/cshperspect.a002584.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"4","key":"1496_CR16","first-page":"133","volume":"17","author":"J Dr\u0105g","year":"2017","unstructured":"Dr\u0105g J, Go\u017adzialska A, Knapik-Czajka M, Matu\u0142a A, Ja\u015bkiewicz J. Nieszczelno\u015b\u0107 jelit w chorobach autoimmunologicznych. Pa\u0144stwo i Spo\u0142ecze\u0144stwo. 2017;17(4):133\u201346.","journal-title":"Pa\u0144stwo i Spo\u0142ecze\u0144stwo"},{"issue":"8","key":"1496_CR17","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1136\/gutjnl-2019-318427","volume":"68","author":"M Camilleri","year":"2019","unstructured":"Camilleri M. Leaky gut: mechanisms, measurement and clinical implications in humans. Gut. 2019;68(8):1516\u201326. https:\/\/doi.org\/10.1136\/gutjnl-2019-318427.","journal-title":"Gut"},{"issue":"5","key":"1496_CR18","doi-asserted-by":"publisher","first-page":"e3309","DOI":"10.1002\/dmrr.3309","volume":"36","author":"LK Wood Heickman","year":"2020","unstructured":"Wood Heickman LK, DeBoer MD, Fasano A. Zonulin as a potential putative biomarker of risk for shared type 1 diabetes and celiac disease autoimmunity. Diabetes Metab Res Rev. 2020;36(5):e3309. https:\/\/doi.org\/10.1002\/dmrr.3309.","journal-title":"Diabetes Metab Res Rev"},{"issue":"8","key":"1496_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0126-x","volume":"50","author":"C Chelakkot","year":"2018","unstructured":"Chelakkot C, Ghim J, Ryu SH. Mechanisms regulating intestinal barrier integrity and its pathological implications. Exp Mol Med. 2018;50(8):1\u20139. https:\/\/doi.org\/10.1038\/s12276-018-0126-x.","journal-title":"Exp Mol Med"},{"issue":"12","key":"1496_CR20","doi-asserted-by":"publisher","first-page":"6634","DOI":"10.1021\/acs.est.7b00423","volume":"51","author":"SL Wright","year":"2017","unstructured":"Wright SL, Kelly FJ. Plastic and human health: a micro issue? Environ Sci Technol. 2017;51(12):6634\u201347. https:\/\/doi.org\/10.1021\/acs.est.7b00423.","journal-title":"Environ Sci Technol"},{"issue":"2","key":"1496_CR21","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3390\/nano11020496","volume":"11","author":"M-L Yee","year":"2021","unstructured":"Yee M-L, Hii L-W, Looi CK, et al. Impact of microplastics and nanoplastics on human health. Nanomaterials. 2021;11(2):496. https:\/\/doi.org\/10.3390\/nano11020496.","journal-title":"Nanomaterials"},{"issue":"1","key":"1496_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/cphc.201900481","volume":"21","author":"O Holloczki","year":"2020","unstructured":"Holloczki O, Gehrke S. Can nanoplastics alter cell membranes? ChemPhysChem. 2020;21(1):9\u201312. https:\/\/doi.org\/10.1002\/cphc.201900481.","journal-title":"ChemPhysChem"},{"issue":"1","key":"1496_CR23","doi-asserted-by":"publisher","first-page":"16013","DOI":"10.1038\/s41598-019-52495-w","volume":"9","author":"O Holloczki","year":"2019","unstructured":"Holloczki O, Gehrke S. Nanoplastics can change the secondary structure of proteins. Sci Rep. 2019;9(1):16013. https:\/\/doi.org\/10.1038\/s41598-019-52495-w.","journal-title":"Sci Rep"},{"key":"1496_CR24","doi-asserted-by":"publisher","first-page":"133794","DOI":"10.1016\/j.scitotenv.2019.133794","volume":"694","author":"M Xu","year":"2019","unstructured":"Xu M, Halimu G, Zhang Q, Song Y, Fu X, Li Y, Li Y, Zhang H. Internalization and toxicity: a preliminary study of effects of nanoplastic particles on human lung epithelial cell. Sci Total Environ. 2019;694:133794. https:\/\/doi.org\/10.1016\/j.scitotenv.2019.133794.","journal-title":"Sci Total Environ"},{"key":"1496_CR25","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.scitotenv.2018.08.353","volume":"649","author":"Y Jin","year":"2019","unstructured":"Jin Y, Lu L, Tu W, Luo T, Fu Z. Impacts of polystyrene microplastic on the gut barrier, microbiota and metabolism of mice. Sci Total Environ. 2019;649:308\u201317. https:\/\/doi.org\/10.1016\/j.scitotenv.2018.08.353.","journal-title":"Sci Total Environ"},{"key":"1496_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12989-016-0123-y","volume":"13","author":"G Vietti","year":"2016","unstructured":"Vietti G, Lison D, van den Brule S. Mechanisms of lung fibrosis induced by carbon nanotubes: towards an adverse outcome pathway (AOP). Part Fibre Toxicol. 2016;13:11. https:\/\/doi.org\/10.1186\/s12989-016-0123-y.","journal-title":"Part Fibre Toxicol"},{"issue":"1","key":"1496_CR27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/15287394.2016.1238329","volume":"80","author":"S Chakraborty","year":"2017","unstructured":"Chakraborty S, Castranova V, Perez MK, Piedimonte G. Nanoparticles-induced apoptosis of human airway epithelium is mediated by proNGF\/p75(NTR) signaling. J Toxicol Environ Health A. 2017;80(1):53\u201368. https:\/\/doi.org\/10.1080\/15287394.2016.1238329.","journal-title":"J Toxicol Environ Health A"},{"issue":"8","key":"1496_CR28","doi-asserted-by":"publisher","first-page":"5294","DOI":"10.1021\/acs.nanolett.8b02291","volume":"18","author":"I Urban\u010di\u010d","year":"2018","unstructured":"Urban\u010di\u010d I, Garvas M, Kokot B, Majaron H, Umek P, Cassidy H, \u0160karabot M, Schneider F, Galiani S, Arsov Z, Koklic T, Matallanas D, \u010ceh M, Mu\u0161evi\u010d I, Eggeling C, \u0160trancar J. Nanoparticles can wrap epithelial cell membranes and relocate them across the epithelial cell layer. Nano Lett. 2018;18(8):5294\u2013305. https:\/\/doi.org\/10.1021\/acs.nanolett.8b02291.","journal-title":"Nano Lett"},{"issue":"8","key":"1496_CR29","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1080\/17435390.2019.1640913","volume":"13","author":"SL Lim","year":"2019","unstructured":"Lim SL, Ng CT, Zou L, Lu Y, Chen J, Bay BH, Shen HM, Ong CN. Targeted metabolomics reveals differential biological effects of nanoplastics and nanoZnO in human lung cells. Nanotoxicology. 2019;13(8):1117\u201332. https:\/\/doi.org\/10.1080\/17435390.2019.1640913.","journal-title":"Nanotoxicology"},{"issue":"6","key":"1496_CR30","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jsps.2017.02.006","volume":"25","author":"AC Kogawa","year":"2017","unstructured":"Kogawa AC, Cernic BG, do Couto LGD, Salgado HRN. Synthetic detergents: 100 years of history. Saudi Pharm J. 2017;25(6):934\u20138. https:\/\/doi.org\/10.1016\/j.jsps.2017.02.006.","journal-title":"Saudi Pharm J"},{"issue":"5","key":"1496_CR31","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1016\/j.jaci.2018.11.016","volume":"143","author":"M Wang","year":"2019","unstructured":"Wang M, Tan G, Eljaszewicz A, Meng Y, Wawrzyniak P, Acharya S, Altunbulakli C, Westermann P, Dreher A, Yan L, Wang C, Akdis M, Zhang L, Nadeau KC, Akdis CA. Laundry detergents and detergent residue after rinsing directly disrupt tight junction barrier integrity in human bronchial epithelial cells. J Allergy Clin Immunol. 2019;143(5):1892\u2013903. https:\/\/doi.org\/10.1016\/j.jaci.2018.11.016.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"1496_CR32","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.jaci.2016.07.003","volume":"138","author":"M Xian","year":"2016","unstructured":"Xian M, Wawrzyniak P, R\u00fcckert B, Duan S, Meng Y, Sokolowska M, Globinska A, Zhang L, Akdis M, Akdis CA. Anionic surfactants and commercial detergents decrease tight junction barrier integrity in human keratinocytes. J Allergy Clin Immunol. 2016;138(3):890-893.e9. https:\/\/doi.org\/10.1016\/j.jaci.2016.07.003.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"1496_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2017.1421885","volume":"9","author":"E Viennois","year":"2018","unstructured":"Viennois E, Chassaing B. First victim, later aggressor: How the intestinal microbiota drives the pro-inflammatory effects of dietary emulsifiers? Gut Microbes. 2018;9(3):1\u20134. https:\/\/doi.org\/10.1080\/19490976.2017.1421885.","journal-title":"Gut Microbes"},{"key":"1496_CR34","first-page":"1","volume":"1","author":"P Pressman","year":"2017","unstructured":"Pressman P, Clemens R, Hayes W, Reddy C. Food additive safety: a review of toxicologic and regulatory issues. Toxicol Res Appl. 2017;1:1\u201322.","journal-title":"Toxicol Res Appl"},{"issue":"7541","key":"1496_CR35","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nature14232","volume":"519","author":"B Chassaing","year":"2015","unstructured":"Chassaing B, Koren O, Goodrich JK, Poole AC, Srinivasan S, Ley RE, Gewirtz AT. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature. 2015;519(7541):92\u20136. https:\/\/doi.org\/10.1038\/nature14232.","journal-title":"Nature"},{"issue":"5","key":"1496_CR36","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.anai.2020.07.013","volume":"125","author":"JW Krempski","year":"2020","unstructured":"Krempski JW, Dant C, Nadeau KC. The origins of allergy from a systems approach. Ann Allergy Asthma Immunol. 2020;125(5):507\u201316. https:\/\/doi.org\/10.1016\/j.anai.2020.07.013.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1496_CR37","doi-asserted-by":"publisher","first-page":"623737","DOI":"10.3389\/fimmu.2021.623737","volume":"12","author":"BSD Fiuza","year":"2021","unstructured":"Fiuza BSD, Fonseca HF, Meirelles PM, Marques CR, da Silva TM, Figueiredo CA. Understanding asthma and allergies by the lens of biodiversity and epigenetic changes. Front Immunol. 2021;12:623737. https:\/\/doi.org\/10.3389\/fimmu.2021.623737.","journal-title":"Front Immunol"},{"issue":"12","key":"1496_CR38","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1111\/all.13634","volume":"73","author":"N Lunjani","year":"2018","unstructured":"Lunjani N, Satitsuksanoa P, Lukasik Z, Sokolowska M, Eiwegger T, O\u2019Mahony L. Recent developments and highlights in mechanisms of allergic diseases: microbiome. Allergy. 2018;73(12):2314\u201327. https:\/\/doi.org\/10.1111\/all.13634.","journal-title":"Allergy"},{"issue":"1","key":"1496_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1939-4551-6-3","volume":"6","author":"T Haahtela","year":"2013","unstructured":"Haahtela T, Holgate S, Pawankar R, Akdis CA, Benjaponpitak S, Caraballo L, Demain J, Portnoy J, von Hertzen L, WAO Special Committee on Climate Change and Biodiversity. The biodiversity hypothesis and allergic disease: world allergy organization position statement. World Allergy Organ J. 2013;6(1):3. https:\/\/doi.org\/10.1186\/1939-4551-6-3.","journal-title":"World Allergy Organ J"},{"issue":"5","key":"1496_CR40","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.jaci.2018.07.005","volume":"142","author":"C Altunbulakli","year":"2018","unstructured":"Altunbulakli C, Reiger M, Neumann AU, Garzorz-Stark N, Fleming M, Huelpuesch C, Castro-Giner F, Eyerich K, Akdis CA, Traidl-Hoffmann C. Relations between epidermal barrier dysregulation and Staphylococcus species-dominated microbiome dysbiosis in patients with atopic dermatitis. J Allergy Clin Immunol. 2018;142(5):1643-1647.e12. https:\/\/doi.org\/10.1016\/j.jaci.2018.07.005.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"1496_CR41","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.jaci.2018.01.046","volume":"142","author":"C Altunbulakli","year":"2018","unstructured":"Altunbulakli C, Costa R, Lan F, Zhang N, Akdis M, Bachert C, Akdis CA. Staphylococcus aureus enhances the tight junction barrier integrity in healthy nasal tissue, but not in nasal polyps. J Allergy Clin Immunol. 2018;142(2):665-668.e8. https:\/\/doi.org\/10.1016\/j.jaci.2018.01.046.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"1496_CR42","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.jhep.2019.08.005","volume":"71","author":"J Mouries","year":"2019","unstructured":"Mouries J, Brescia P, Silvestri A, Spadoni I, Sorribas M, Wiest R, Mileti E, Galbiati M, Invernizzi P, Adorini L, Penna G, Rescigno M. Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development. J Hepatol. 2019;71(6):1216\u201328. https:\/\/doi.org\/10.1016\/j.jhep.2019.08.005.","journal-title":"J Hepatol"},{"issue":"2","key":"1496_CR43","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.jaip.2018.08.020","volume":"7","author":"YC Kim","year":"2019","unstructured":"Kim YC, Won HK, Lee JW, Sohn KH, Kim MH, Kim TB, Chang YS, Lee BJ, Cho SH, Bachert C, Song WJ. Staphylococcus aureus nasal colonization and asthma in adults: systematic review and meta-analysis. J Allergy Clin Immunol Pract. 2019;7(2):606-615.e9. https:\/\/doi.org\/10.1016\/j.jaip.2018.08.020.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"19","key":"1496_CR44","doi-asserted-by":"publisher","first-page":"4871","DOI":"10.3390\/ijms20194871","volume":"20","author":"JW Kim","year":"2019","unstructured":"Kim JW, Kwok SK, Choe JY, Park SH. Recent advances in our understanding of the link between the intestinal microbiota and systemic lupus erythematosus. Int J Mol Sci. 2019;20(19):4871. https:\/\/doi.org\/10.3390\/ijms20194871.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1496_CR45","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1042\/CS20180087","volume":"132","author":"S Kim","year":"2018","unstructured":"Kim S, Goel R, Kumar A, Qi Y, Lobaton G, Hosaka K, Mohammed M, Handberg EM, Richards EM, Pepine CJ, Raizada MK. Imbalance of gut microbiome and intestinal epithelial barrier dysfunction in patients with high blood pressure. Clin Sci. 2018;132(6):701\u201318. https:\/\/doi.org\/10.1042\/CS20180087.","journal-title":"Clin Sci"},{"issue":"6","key":"1496_CR46","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/j.1365-2133.1994.tb03414.x","volume":"130","author":"E S\u00f8yland","year":"1994","unstructured":"S\u00f8yland E, Funk J, Rajka G, Sandberg M, Thune P, Rustad L, Helland S, Middelfart K, Odu S, Falk ES, et al. Dietary supplementation with very long-chain n-3 fatty acids in patients with atopic dermatitis: a double-blind, multicentre study. Br J Dermatol. 1994;130(6):757\u201364. https:\/\/doi.org\/10.1111\/j.1365-2133.1994.tb03414.x.","journal-title":"Br J Dermatol"},{"issue":"1","key":"1496_CR47","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jaci.2019.01.043","volume":"144","author":"M Hussain","year":"2019","unstructured":"Hussain M, Bonilla-Rosso G, Kwong Chung CKC, B\u00e4riswyl L, Rodriguez MP, Kim BS, Engel P, Noti M. High dietary fat intake induces a microbiota signature that promotes food allergy. J Allergy Clin Immunol. 2019;144(1):157-170.e8. https:\/\/doi.org\/10.1016\/j.jaci.2019.01.043.","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"1496_CR48","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1111\/cea.12928","volume":"47","author":"H Yamashita","year":"2017","unstructured":"Yamashita H, Matsuhara H, Miotani S, Sako Y, Matsui T, Tanaka H, Inagaki N. Artificial sweeteners and mixture of food additives cause to break oral tolerance and induce food allergy in murine oral tolerance model for food allergy. Clin Exp Allergy. 2017;47(9):1204\u201313. https:\/\/doi.org\/10.1111\/cea.12928.","journal-title":"Clin Exp Allergy"},{"issue":"8","key":"1496_CR49","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1111\/all.13764","volume":"74","author":"C Venter","year":"2019","unstructured":"Venter C, Meyer RW, Nwaru BI, Roduit C, Untersmayr E, Adel-Patient K, Agache I, Agostoni C, Akdis CA, Bischoff SC, du Toit G, Feeney M, Frei R, Garn H, Greenhawt M, Hoffmann-Sommergruber K, Lunjani N, Maslin K, Mills C, Muraro A, Pali-Sch\u00f6ll I, Poulson LK, Reese I, Renz H, Roberts GC, Smith P, Smolinska S, Sokolowska M, Stanton C, Vlieg-Boerstra B, O\u2019Mahony L. EAACI position paper: Influence of dietary fatty acids on asthma, food allergy, and atopic dermatitis. Allergy. 2019;74(8):1429\u201344. https:\/\/doi.org\/10.1111\/all.13764.","journal-title":"Allergy"},{"issue":"6","key":"1496_CR50","doi-asserted-by":"publisher","first-page":"946","DOI":"10.2174\/138161282006140220125732","volume":"20","author":"EA Miles","year":"2014","unstructured":"Miles EA, Calder PC. Omega-6 and omega-3 polyunsaturated fatty acids and allergic diseases in infancy and childhood. Curr Pharm Des. 2014;20(6):946\u201353. https:\/\/doi.org\/10.2174\/138161282006140220125732.","journal-title":"Curr Pharm Des"},{"key":"1496_CR51","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.plefa.2018.03.004","volume":"132","author":"JK Innes","year":"2018","unstructured":"Innes JK, Calder PC. Omega-6 fatty acids and inflammation. Prostaglandins Leukot Essent Fatty Acids. 2018;132:41\u20138. https:\/\/doi.org\/10.1016\/j.plefa.2018.03.004.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"12","key":"1496_CR52","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1038\/s41590-018-0256-2","volume":"19","author":"T Dainichi","year":"2018","unstructured":"Dainichi T, Kitoh A, Otsuka A, Nakajima S, Nomura T, Kaplan DH, Kabashima K. The epithelial immune microenvironment (EIME) in atopic dermatitis and psoriasis. Nat Immunol. 2018;19(12):1286\u201398. https:\/\/doi.org\/10.1038\/s41590-018-0256-2.","journal-title":"Nat Immunol"},{"issue":"3\u20134","key":"1496_CR53","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00281-003-0148-9","volume":"25","author":"GA Rook","year":"2004","unstructured":"Rook GA, Adams V, Hunt J, Palmer R, Martinelli R, Brunet LR. Mycobacteria and other environmental organisms as immunomodulators for immunoregulatory disorders. Springer Semin Immunopathol. 2004;25(3\u20134):237\u201355. https:\/\/doi.org\/10.1007\/s00281-003-0148-9.","journal-title":"Springer Semin Immunopathol"},{"key":"1496_CR54","doi-asserted-by":"publisher","first-page":"104962","DOI":"10.1016\/j.phrs.2020.104962","volume":"159","author":"S Panelli","year":"2020","unstructured":"Panelli S, Epis S, Cococcioni L, Perini M, Paroni M, Bandi C, Drago L, Zuccotti GV. Inflammatory bowel diseases, the hygiene hypothesis and the other side of the microbiota: parasites and fungi. Pharmacol Res. 2020;159:104962. https:\/\/doi.org\/10.1016\/j.phrs.2020.104962.","journal-title":"Pharmacol Res"},{"key":"1496_CR55","doi-asserted-by":"publisher","first-page":"598","DOI":"10.3389\/fimmu.2017.00598","volume":"8","author":"Q Mu","year":"2017","unstructured":"Mu Q, Kirby J, Reilly CM, Luo XM. Leaky gut as a danger signal for autoimmune diseases. Front Immunol. 2017;8:598. https:\/\/doi.org\/10.3389\/fimmu.2017.00598.","journal-title":"Front Immunol"},{"issue":"4","key":"1496_CR56","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/imm.13117","volume":"158","author":"AT Soderholm","year":"2019","unstructured":"Soderholm AT, Pedicord VA. Intestinal epithelial cells: at the interface of the microbiota and mucosal immunity. Immunology. 2019;158(4):267\u201380. https:\/\/doi.org\/10.1111\/imm.13117.","journal-title":"Immunology"},{"issue":"5","key":"1496_CR57","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.autrev.2019.03.006","volume":"18","author":"X Meng","year":"2019","unstructured":"Meng X, Zhou HY, Shen HH, Lufumpa E, Li XM, Guo B, Li BZ. Microbe-metabolite-host axis, two-way action in the pathogenesis and treatment of human autoimmunity. Autoimmun Rev. 2019;18(5):455\u201375. https:\/\/doi.org\/10.1016\/j.autrev.2019.03.006.","journal-title":"Autoimmun Rev"},{"issue":"3","key":"1496_CR58","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S2213-8587(14)70134-2","volume":"3","author":"AJ Cox","year":"2015","unstructured":"Cox AJ, West NP, Cripps AW. Obesity, inflammation, and the gut microbiota. Lancet Diabetes Endocrinol. 2015;3(3):207\u201315. https:\/\/doi.org\/10.1016\/S2213-8587(14)70134-2.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"1496_CR59","doi-asserted-by":"publisher","first-page":"363","DOI":"10.5056\/jnm19044","volume":"25","author":"SK Dutta","year":"2019","unstructured":"Dutta SK, Verma S, Jain V, Surapaneni BK, Vinayek R, Phillips L, Nair PP. Parkinson\u2019s disease: the emerging role of gut dysbiosis, antibiotics, probiotics, and fecal microbiota transplantation. J Neurogastroenterol Motil. 2019;25(3):363\u201376. https:\/\/doi.org\/10.5056\/jnm19044.","journal-title":"J Neurogastroenterol Motil"},{"issue":"3","key":"1496_CR60","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00401-018-1856-5","volume":"136","author":"C Pellegrini","year":"2018","unstructured":"Pellegrini C, Antonioli L, Colucci R, Blandizzi C, Fornai M. Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: a common path to neurodegenerative diseases? Acta Neuropathol. 2018;136(3):345\u201361. https:\/\/doi.org\/10.1007\/s00401-018-1856-5.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"1496_CR61","doi-asserted-by":"publisher","first-page":"224","DOI":"10.4161\/gmic.1.4.12613","volume":"1","author":"T Tanoue","year":"2010","unstructured":"Tanoue T, Umesaki Y, Honda K. Immune responses to gut microbiota-commensals and pathogens. Gut Microbes. 2010;1(4):224\u201333. https:\/\/doi.org\/10.4161\/gmic.1.4.12613.","journal-title":"Gut Microbes"},{"key":"1496_CR62","doi-asserted-by":"publisher","first-page":"2340670","DOI":"10.1155\/2020\/2340670","volume":"2020","author":"L Chunxi","year":"2020","unstructured":"Chunxi L, Haiyue L, Yanxia L, Jianbing P, Jin S. The gut microbiota and respiratory diseases: new evidence. J Immunol Res. 2020;2020:2340670. https:\/\/doi.org\/10.1155\/2020\/2340670.","journal-title":"J Immunol Res"},{"issue":"10","key":"1496_CR63","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.dld.2006.06.012","volume":"38","author":"MT Ventura","year":"2006","unstructured":"Ventura MT, Polimeno L, Amoruso AC, Gatti F, Annoscia E, Marinaro M, Di Leo E, Matino MG, Buquicchio R, Bonini S, Tursi A, Francavilla A. Intestinal permeability in patients with adverse reactions to food. Dig Liver Dis. 2006;38(10):732\u20136. https:\/\/doi.org\/10.1016\/j.dld.2006.06.012.","journal-title":"Dig Liver Dis"},{"issue":"39","key":"1496_CR64","doi-asserted-by":"publisher","first-page":"16799","DOI":"10.1073\/pnas.0906773106","volume":"106","author":"A Tripathi","year":"2009","unstructured":"Tripathi A, Lammers KM, Goldblum S, Shea-Donohue T, Netzel-Arnett S, Buzza MS, Antalis TM, Vogel SN, Zhao A, Yang S, Arrietta MC, Meddings JB, Fasano A. Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proc Natl Acad Sci USA. 2009;106(39):16799\u2013804. https:\/\/doi.org\/10.1073\/pnas.0906773106.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"1496_CR65","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1136\/annrheumdis-2016-210000","volume":"76","author":"F Ciccia","year":"2017","unstructured":"Ciccia F, Guggino G, Rizzo A, Alessandro R, Luchetti MM, Milling S, Saieva L, Cypers H, Stampone T, Di Benedetto P, Gabrielli A, Fasano A, Elewaut D, Triolo G. Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis. Ann Rheum Dis. 2017;76(6):1123\u201332. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210000.","journal-title":"Ann Rheum Dis"},{"key":"1496_CR66","doi-asserted-by":"publisher","unstructured":"El Asmar R, Panigrahi P, Bamford P, Berti I, Not T, Coppa GV, Catassi C, Fasano A. (2002) Host-dependent zonulin secretion causes the impairment of the small intestine barrier function after bacterial exposure. Gastroenterology 123(5):1607\u201315. https:\/\/doi.org\/10.1053\/gast.2002.36578. Erratum in: 2003, Gastroenterology124(1):275.","DOI":"10.1053\/gast.2002.36578"},{"issue":"1","key":"1496_CR67","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1053\/j.gastro.2008.03.023","volume":"135","author":"KM Lammers","year":"2008","unstructured":"Lammers KM, Lammers KM, Lu R, Brownley J, Lu B, Gerard C, Thomas K, Rallabhandi P, Shea-Donohue T, Tamiz A, Alkan S, Netzel-Arnett S, Antalis T, Vogel SN, Fasano A. Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology. 2008;135(1):194-204.e3. https:\/\/doi.org\/10.1053\/j.gastro.2008.03.023.","journal-title":"Gastroenterology"},{"issue":"4","key":"1496_CR68","doi-asserted-by":"publisher","first-page":"e1251384","DOI":"10.1080\/21688370.2016.1251384","volume":"4","author":"C Sturgeon","year":"2016","unstructured":"Sturgeon C, Fasano A. Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases. Tissue Barriers. 2016;4(4):e1251384. https:\/\/doi.org\/10.1080\/21688370.2016.1251384.","journal-title":"Tissue Barriers"},{"issue":"1","key":"1496_CR69","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/nyas.13343","volume":"1397","author":"C Sturgeon","year":"2017","unstructured":"Sturgeon C, Lan J, Fasano A. Zonulin transgenic mice show altered gut permeability and increased morbidity\/mortality in the DSS colitis model. Ann NY Acad Sci. 2017;1397(1):130\u201342. https:\/\/doi.org\/10.1111\/nyas.13343.","journal-title":"Ann NY Acad Sci"},{"key":"1496_CR70","doi-asserted-by":"publisher","first-page":"1092118","DOI":"10.3389\/fcimb.2023.1092118","volume":"13","author":"MDS Romero-Figueroa","year":"2023","unstructured":"Romero-Figueroa MDS, Ram\u00edrez-Dur\u00e1n N, Montiel-Jarqu\u00edn AJ, Horta-Baas G. Gut-joint axis: Gut dysbiosis can contribute to the onset of rheumatoid arthritis via multiple pathways. Front Cell Infect Microbiol. 2023;13:1092118. https:\/\/doi.org\/10.3389\/fcimb.2023.1092118.","journal-title":"Front Cell Infect Microbiol"},{"key":"1496_CR71","doi-asserted-by":"publisher","first-page":"1007610","DOI":"10.3389\/fimmu.2022.1007610","volume":"13","author":"X Xu","year":"2022","unstructured":"Xu X, Wang M, Wang Z, Chen Q, Chen X, Xu Y, Dai M, Wu B, Li Y. The bridge of the gut-joint axis: Gut microbial metabolites in rheumatoid arthritis. Front Immunol. 2022;13:1007610. https:\/\/doi.org\/10.3389\/fimmu.2022.1007610.","journal-title":"Front Immunol"},{"key":"1496_CR72","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac454","author":"R Audo","year":"2022","unstructured":"Audo R, Sanchez P, Rivi\u00e8re B, Mielle J, Tan J, Lukas C, Macia L, Morel J, Immediato Daien C. Rheumatoid arthritis is associated with increased gut permeability and bacterial translocation which are reversed by inflammation control. Rheumatology. 2022. https:\/\/doi.org\/10.1093\/rheumatology\/keac454.","journal-title":"Rheumatology"},{"issue":"1","key":"1496_CR73","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1038\/s41467-020-15831-7","volume":"11","author":"N Tajik","year":"2020","unstructured":"Tajik N, Frech M, Schulz O, Sch\u00e4lter F, Lucas S, Azizov V, D\u00fcrholz K, Steffen F, Omata Y, Rings A, Bertog M, Rizzo A, Iljazovic A, Basic M, Kleyer A, Culemann S, Kr\u00f6nke G, Luo Y, \u00dcberla K, Gaipl US, Frey B, Strowig T, Sarter K, Bischoff SC, Wirtz S, Ca\u00f1ete JD, Ciccia F, Schett G, Zaiss MM. Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis. Nat Commun. 2020;11(1):1995. https:\/\/doi.org\/10.1038\/s41467-020-15831-7.","journal-title":"Nat Commun"},{"issue":"1","key":"1496_CR74","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/BOR.0000000000000239","volume":"28","author":"F Ciccia","year":"2016","unstructured":"Ciccia F, Rizzo A, Triolo G. Subclinical gut inflammation in ankylosing spondylitis. Curr Opin Rheumatol. 2016;28(1):89\u201396. https:\/\/doi.org\/10.1097\/BOR.0000000000000239.","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"1496_CR75","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/BOR.0000000000000296","volume":"28","author":"CF Ciccia","year":"2016","unstructured":"Ciccia CF, Ferrante A, Triolo G. Intestinal dysbiosis and innate immune responses in axial spondyloarthritis. Curr Opin Rheumatol. 2016;28(4):352\u20138. https:\/\/doi.org\/10.1097\/BOR.0000000000000296.","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"1496_CR76","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1152\/physrev.00003.2008","volume":"91","author":"A Fasano","year":"2011","unstructured":"Fasano A. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol Rev. 2011;91(1):151\u201375. https:\/\/doi.org\/10.1152\/physrev.00003.2008.","journal-title":"Physiol Rev"},{"key":"1496_CR77","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.3389\/fimmu.2019.02233","volume":"10","author":"A Miranda-Ribera","year":"2019","unstructured":"Miranda-Ribera A, Miranda-Ribera A, Ennamorati M, Serena G, Cetinbas M, Lan J, Sadreyev RI, Jain N, Fasano A, Fiorentino M. Exploiting the zonulin mouse model to establish the role of primary impaired gut barrier function on microbiota composition and immune profiles. Front Immunol. 2019;10:2233. https:\/\/doi.org\/10.3389\/fimmu.2019.02233.","journal-title":"Front Immunol"},{"issue":"2","key":"1496_CR78","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.jcmgh.2015.01.001","volume":"1","author":"J Luther","year":"2015","unstructured":"Luther J, Garber JJ, Khalili H, Dave M, Bale SS, Jindal R, Motola DL, Luther S, Bohr S, Jeoung SW, Deshpande V, Singh G, Turner JR, Yarmush ML, Chung RT, Patel SJ. Hepatic injury in nonalcoholic steatohepatitis contributes to altered intestinal permeability. Cell Mol Gastroenterol Hepatol. 2015;1(2):222\u201332. https:\/\/doi.org\/10.1016\/j.jcmgh.2015.01.001.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"7","key":"1496_CR79","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1080\/17474124.2018.1481747","volume":"12","author":"FR Ponziani","year":"2018","unstructured":"Ponziani FR, Zocco MA, Cerrito L, Gasbarrini A, Pompili M. Bacterial translocation in patients with liver cirrhosis: physiology, clinical consequences, and practical implications. Expert Rev Gastroenterol Hepatol. 2018;12(7):641\u201356. https:\/\/doi.org\/10.1080\/17474124.2018.1481747.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"1496_CR80","doi-asserted-by":"publisher","first-page":"175883591984818","DOI":"10.1177\/1758835919848184","volume":"11","author":"FR Ponziani","year":"2019","unstructured":"Ponziani FR, Nicoletti A, Gasbarrini A, Pompili M. Diagnostic and therapeutic potential of the gut microbiota in patients with early hepatocellular carcinoma. Ther Adv Med Oncol. 2019;11:1758835919848184. https:\/\/doi.org\/10.1177\/1758835919848184.","journal-title":"Ther Adv Med Oncol"},{"issue":"12","key":"1496_CR81","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/nri.2017.100","volume":"17","author":"I Spadoni","year":"2017","unstructured":"Spadoni I, Fornasa G, Rescigno M. Organ-specific protection mediated by cooperation between vascular and epithelial barriers. Nat Rev Immunol. 2017;17(12):761\u201373. https:\/\/doi.org\/10.1038\/nri.2017.100.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"1496_CR82","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nri3608","volume":"14","author":"LW Peterson","year":"2014","unstructured":"Peterson LW, Artis D. Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat Rev Immunol. 2014;14(3):141\u201353. https:\/\/doi.org\/10.1038\/nri3608.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"1496_CR83","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1083\/jcb.200302070","volume":"161","author":"T Nitta","year":"2003","unstructured":"Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, Hashimoto N, Furuse M, Tsukita S. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol. 2003;161(3):653\u201360. https:\/\/doi.org\/10.1083\/jcb.200302070.","journal-title":"J Cell Biol"},{"issue":"3","key":"1496_CR84","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1177\/1479164116683149","volume":"14","author":"NK Acharya","year":"2017","unstructured":"Acharya NK, Qi X, Goldwaser EL, Godsey GA, Wu H, Kosciuk MC, Freeman TA, Macphee CH, Wilensky RL, Venkataraman V, Nagele RG. Retinal pathology is associated with increased blood-retina barrier permeability in a diabetic and hypercholesterolaemic pig model: Beneficial effects of the LpPLA2 inhibitor Darapladib. Diab Vasc Dis Res. 2017;14(3):200\u201313. https:\/\/doi.org\/10.1177\/1479164116683149.","journal-title":"Diab Vasc Dis Res"},{"key":"1496_CR85","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3389\/fcimb.2017.00381","volume":"7","author":"Q Yan","year":"2017","unstructured":"Yan Q, Gu Y, Li X, Yang W, Jia L, Chen C, Han X, Huang Y, Zhao L, Li P, Fang Z, Zhou J, Guan X, Ding Y, Wang S, Khan M, Xin Y, Li S, Ma Y. Alterations of the gut microbiome in hypertension. Front Cell Infect Microbiol. 2017;7:381. https:\/\/doi.org\/10.3389\/fcimb.2017.00381.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"1496_CR86","doi-asserted-by":"publisher","first-page":"2195135","DOI":"10.1080\/10641963.2023.2195135","volume":"45","author":"Z Yang","year":"2023","unstructured":"Yang Z, Wang Q, Liu Y, Wang L, Ge Z, Li Z, Feng S, Wu C. Gut microbiota and hypertension: association, mechanisms and treatment. Clin Exp Hypertens. 2023;45(1):2195135. https:\/\/doi.org\/10.1080\/10641963.2023.2195135.","journal-title":"Clin Exp Hypertens"},{"issue":"1","key":"1496_CR87","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40168-016-0222-x","volume":"5","author":"J Li","year":"2017","unstructured":"Li J, Zhao F, Wang Y, Chen J, Tao J, Tian G, Wu S, Liu W, Cui Q, Geng B, Zhang W, Weldon R, Auguste K, Yang L, Liu X, Chen L, Yang X, Zhu B, Cai J. Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome. 2017;5(1):14. https:\/\/doi.org\/10.1186\/s40168-016-0222-x.","journal-title":"Microbiome"},{"key":"1496_CR88","volume-title":"Assocation between hypertension and impairment of intestinal barrier function","author":"D Lin","year":"2019","unstructured":"Lin D. Assocation between hypertension and impairment of intestinal barrier function. Guangzhong: Guangdong Pharmaceutical University; 2019."},{"issue":"2","key":"1496_CR89","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1161\/CIRCRESAHA","volume":"120","author":"MM Santisteban","year":"2017","unstructured":"Santisteban MM, Qi Y, Zubcevic J, Kim S, Yang T, Shenoy V, Cole-Jeffrey CT, Lobaton GO, Stewart DC, Rubiano A, Simmons CS, Garcia-Pereira F, Johnson RD, Pepine CJ, Raizada MK. Hypertension-linked pathophysiological alterations in the gut. Circ Res. 2017;120(2):312\u201323. https:\/\/doi.org\/10.1161\/CIRCRESAHA.","journal-title":"Circ Res"},{"issue":"6","key":"1496_CR90","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/hiv.12015","volume":"14","author":"IW Manner","year":"2013","unstructured":"Manner IW, Baekken M, Kvale D, Oektedalen O, Pedersen M, Nielsen SD, Nowak P, Os I, Troseid M. Markers of microbial translocation predict hypertension in HIV-infected individuals. HIV Med. 2013;14(6):354\u201361. https:\/\/doi.org\/10.1111\/hiv.12015.","journal-title":"HIV Med"},{"issue":"12","key":"1496_CR91","doi-asserted-by":"publisher","first-page":"e0189310","DOI":"10.1371\/journal.pone.0189310","volume":"12","author":"K Jaworska","year":"2017","unstructured":"Jaworska K, Huc T, Samborowska E, Dobrowolski L, Bielinska K, Gawlak M, Ufnal M, Chamaillard M. Hypertension in rats is associated with an increased permeability of the colon to TMA, a gut bacteria metabolite. PLoS ONE. 2017;12(12):e0189310. https:\/\/doi.org\/10.1371\/journal.pone.0189310.","journal-title":"PLoS ONE"},{"issue":"2","key":"1496_CR92","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/MOG.0000000000000243","volume":"32","author":"EM Quigley","year":"2016","unstructured":"Quigley EM. Leaky gut: concept or clinical entity? Curr Opin Gastroenterol. 2016;32(2):74\u20139. https:\/\/doi.org\/10.1097\/MOG.0000000000000243.","journal-title":"Curr Opin Gastroenterol"},{"issue":"1","key":"1496_CR93","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrgastro.2016.169","volume":"14","author":"JR Turner","year":"2017","unstructured":"Turner JR, Odenwald MA, Turner JR. The intestinal epithelial barrier: a therapeutic target? Nat Rev Gastroenterol Hepatol. 2017;14(1):9\u201321. https:\/\/doi.org\/10.1038\/nrgastro.2016.169.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1496_CR94","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/628157","author":"A Michielan","year":"2015","unstructured":"Michielan A, Michielan A, Dinc\u00e0 R. Intestinal permeability in inflammatory bowel disease: pathogenesis, clinical evaluation, and therapy of leaky gut. Mediators Inflamm. 2015. https:\/\/doi.org\/10.1155\/2015\/628157.","journal-title":"Mediators Inflamm"},{"issue":"23","key":"1496_CR95","doi-asserted-by":"publisher","first-page":"12836","DOI":"10.3390\/ijerph182312836","volume":"18","author":"N Di Tommaso","year":"2021","unstructured":"Di Tommaso N, Gasbarrini A, Ponziani FR. Intestinal barrier in human health and disease. Int J Environ Res Public Health. 2021;18(23):12836. https:\/\/doi.org\/10.3390\/ijerph182312836.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"1496_CR96","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3748\/wjg.v20.i1.91","volume":"20","author":"YZ Zhang","year":"2014","unstructured":"Zhang YZ, Li YY. Inflammatory bowel disease: pathogenesis. World J Gastroenterol. 2014;20(1):91\u20139. https:\/\/doi.org\/10.3748\/wjg.v20.i1.91.","journal-title":"World J Gastroenterol"},{"key":"1496_CR97","doi-asserted-by":"publisher","first-page":"493012","DOI":"10.1155\/2015\/493012","volume":"2015","author":"BR de Mattos","year":"2015","unstructured":"de Mattos BR, Garcia MP, Nogueira JB, Paiatto LN, Albuquerque CG, Souza CL, Fernandes LG, Tamashiro WM, Simioni PU. Inflammatory bowel disease: an overview of immune mechanisms and biological treatments. Mediators Inflamm. 2015;2015:493012. https:\/\/doi.org\/10.1155\/2015\/493012.","journal-title":"Mediators Inflamm"},{"issue":"1","key":"1496_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12328-017-0813-5","volume":"11","author":"A Nishida","year":"2018","unstructured":"Nishida A, Inoue R, Inatomi O, Bamba S, Naito Y, Andoh A. Gut microbiota in the pathogenesis of inflammatory bowel disease. Clin J Gastroenterol. 2018;11(1):1\u201310. https:\/\/doi.org\/10.1007\/s12328-017-0813-5.","journal-title":"Clin J Gastroenterol"},{"issue":"2","key":"1496_CR99","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41575-020-00399-w","volume":"18","author":"S Mehandru","year":"2021","unstructured":"Mehandru S, Colombel JF. The intestinal barrier, an arbitrator turned provocateur in IBD. Nat Rev Gastroenterol Hepatol. 2021;18(2):83\u20134. https:\/\/doi.org\/10.1038\/s41575-020-00399-w.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"1496_CR100","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1053\/j.gastro.2020.08.005","volume":"159","author":"W Turpin","year":"2020","unstructured":"Turpin W, Lee SH, Raygoza Garay JA, Madsen KL, Meddings JB, Bedrani L, Power N, Espin-Garcia O, Xu W, Smith MI, Griffiths AM, Moayyedi P, Turner D, Seidman EG, Steinhart AH, Marshall JK, Jacobson K, Mack D, Huynh H, Bernstein CN, Paterson AD, Croitoru K, Crohn\u2019s and Colitis Canada Genetic Environmental Microbial Project Research Consortium; CCC GEM Project recruitment site directors include Maria Abreu. Increased intestinal permeability is associated with later development of crohn\u2019s disease. Gastroenterology. 2020;159(6):2092-2100.e5. https:\/\/doi.org\/10.1053\/j.gastro.2020.08.005.","journal-title":"Gastroenterology"},{"issue":"6","key":"1496_CR101","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1159\/000324281","volume":"28","author":"G Szabo","year":"2010","unstructured":"Szabo G, Bala S, Petrasek J, Gattu A. Gut-liver axis and sensing microbes. Dig Dis. 2010;28(6):737\u201344. https:\/\/doi.org\/10.1159\/000324281.","journal-title":"Dig Dis"},{"issue":"3","key":"1496_CR102","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","volume":"72","author":"A Albillos","year":"2020","unstructured":"Albillos A, de Gottardi A, Rescigno M. The gut-liver axis in liver disease: Pathophysiological basis for therapy. J Hepatol. 2020;72(3):558\u201377. https:\/\/doi.org\/10.1016\/j.jhep.2019.10.003.","journal-title":"J Hepatol"},{"key":"1496_CR103","doi-asserted-by":"publisher","unstructured":"Wiest R, Albillos A, Trauner M, Bajaj JS, Jalan R (2017) Targeting the gut-liver axis in liver disease. J Hepatol. Nov;67(5):1084\u20131103. https:\/\/doi.org\/10.1016\/j.jhep.2017.05.007. Erratum in: J Hepatol. 2018.","DOI":"10.1016\/j.jhep.2017.05.007"},{"issue":"1","key":"1496_CR104","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jhep.2013.07.044","volume":"60","author":"R Wiest","year":"2014","unstructured":"Wiest R, Lawson M, Geuking M. Pathological bacterial translocation in liver cirrhosis. J Hepatol. 2014;60(1):197\u2013209. https:\/\/doi.org\/10.1016\/j.jhep.2013.07.044.","journal-title":"J Hepatol"},{"key":"1496_CR105","doi-asserted-by":"publisher","unstructured":"J Tripathi A, Debelius J, Brenner DA, Karin M, Loomba R, Schnabl B, Knight R (2018) The gut-liver axis and the intersection with the microbiome. Nat Rev Gastroenterol Hepatol 15(7):397\u2013411. https:\/\/doi.org\/10.1038\/s41575-018-0011-z. Erratum in: Nat Rev Gastroenterol Hepatol. 2018.","DOI":"10.1038\/s41575-018-0011-z"},{"issue":"2","key":"1496_CR106","first-page":"163","volume":"38","author":"F Bishehsari","year":"2017","unstructured":"Bishehsari F, Magno E, Swanson G, Desai V, Voigt RM, Forsyth CB, Keshavarzian A. Alcohol and gut-derived inflammation. Alcohol Res. 2017;38(2):163\u201371.","journal-title":"Alcohol Res"},{"issue":"1","key":"1496_CR107","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/j.1572-0241.1999.00797.x","volume":"94","author":"A Keshavarzian","year":"1999","unstructured":"Keshavarzian A, Holmes EW, Patel M, Iber F, Fields JZ, Pethkar S. Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage. Am J Gastroenterol. 1999;94(1):200\u20137. https:\/\/doi.org\/10.1111\/j.1572-0241.1999.00797.x.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"1496_CR108","doi-asserted-by":"publisher","first-page":"1782157","DOI":"10.1080\/19490976.2020.1782157","volume":"12","author":"L Maccioni","year":"2020","unstructured":"Maccioni L, Gao B, Leclercq S, Pirlot B, Horsmans Y, De Timary P, Leclercq I, Fouts D, Schnabl B, St\u00e4rkel P. Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans. Gut Microbes. 2020;12(1):1782157. https:\/\/doi.org\/10.1080\/19490976.2020.1782157.","journal-title":"Gut Microbes"},{"issue":"21","key":"1496_CR109","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1212\/WNL.0b013e3181c34af5","volume":"73","author":"R Savica","year":"2009","unstructured":"Savica R, Carlin JM, Grossardt BR, Bower JH, Ahlskog JE, Maraganore DM, Bharucha AE, Rocca WA. Medical records documentation of constipation preceding Parkinson disease: a case-control study. Neurology. 2009;73(21):1752\u20138. https:\/\/doi.org\/10.1212\/WNL.0b013e3181c34af5.","journal-title":"Neurology"},{"issue":"6","key":"1496_CR110","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/mds.23838","volume":"27","author":"KM Shannon","year":"2012","unstructured":"Shannon KM, Keshavarzian A, Mutlu E, Dodiya HB, Daian D, Jaglin JA, Kordower JH. Alpha-synuclein in colonic submucosa in early untreated Parkinson\u2019s disease. Mov Disord. 2012;27(6):709\u201315. https:\/\/doi.org\/10.1002\/mds.23838.","journal-title":"Mov Disord"},{"issue":"4","key":"1496_CR111","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","volume":"103","author":"S Kim","year":"2019","unstructured":"Kim S, Kwon SH, Kam TI, Panicker N, Karuppagounder SS, Lee S, Lee JH, Kim WR, Kook M, Foss CA, Shen C, Lee H, Kulkarni S, Pasricha PJ, Lee G, Pomper MG, Dawson VL, Dawson TM, Ko HS. Transneuronal propagation of pathologic \u03b1-synuclein from the gut to the brain models parkinson\u2019s disease. Neuron. 2019;103(4):627-641.e7. https:\/\/doi.org\/10.1016\/j.neuron.2019.05.035.","journal-title":"Neuron"},{"issue":"Suppl 1","key":"1496_CR112","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1542\/peds.2009-1878C","volume":"125","author":"T Buie","year":"2010","unstructured":"Buie T, Campbell DB, Fuchs GJ 3rd, Furuta GT, Levy J, Vandewater J, Whitaker AH, Atkins D, Bauman ML, Beaudet AL, Carr EG, Gershon MD, Hyman SL, Jirapinyo P, Jyonouchi H, Kooros K, Kushak R, Levitt P, Levy SE, Lewis JD, Murray KF, Natowicz MR, Sabra A, Wershil BK, Weston SC, Zeltzer L, Winter H. Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics. 2010;125(Suppl 1):S1-18. https:\/\/doi.org\/10.1542\/peds.2009-1878C.","journal-title":"Pediatrics"},{"issue":"7","key":"1496_CR113","doi-asserted-by":"publisher","first-page":"e68322","DOI":"10.1371\/journal.pone.0068322","volume":"8","author":"DW Kang","year":"2013","unstructured":"Kang DW, Park JG, Ilhan ZE, Wallstrom G, Labaer J, Adams JB, Krajmalnik-Brown R. Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children. PLoS ONE. 2013;8(7):e68322. https:\/\/doi.org\/10.1371\/journal.pone.0068322.","journal-title":"PLoS ONE"},{"key":"1496_CR114","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13229-016-0110-z","volume":"7","author":"M Fiorentino","year":"2016","unstructured":"Fiorentino M, Sapone A, Senger S, Camhi SS, Kadzielski SM, Buie TM, Kelly DL, Cascella N, Fasano A. Blood-brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders. Mol Autism. 2016;7:49. https:\/\/doi.org\/10.1186\/s13229-016-0110-z.","journal-title":"Mol Autism"},{"issue":"1","key":"1496_CR115","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40168-017-0242-1","volume":"5","author":"F Strati","year":"2017","unstructured":"Strati F, Cavalieri D, Albanese D, De Felice C, Donati C, Hayek J, Jousson O, Leoncini S, Renzi D, Calabr\u00f2 A, De Filippo C. New evidences on the altered gut microbiota in autism spectrum disorders. Microbiome. 2017;5(1):24. https:\/\/doi.org\/10.1186\/s40168-017-0242-1.","journal-title":"Microbiome"},{"key":"1496_CR116","doi-asserted-by":"publisher","first-page":"571731","DOI":"10.3389\/fimmu.2020.571731","volume":"11","author":"TPM Scheithauer","year":"2020","unstructured":"Scheithauer TPM, Rampanelli E, Nieuwdorp M, Vallance BA, Verchere CB, van Raalte DH, Herrema H. Gut microbiota as a trigger for metabolic inflammation in obesity and type 2 diabetes. Front Immunol. 2020;11:571731. https:\/\/doi.org\/10.3389\/fimmu.2020.571731.","journal-title":"Front Immunol"},{"issue":"10","key":"1496_CR117","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1136\/gutjnl-2019-320118","volume":"69","author":"L Massier","year":"2020","unstructured":"Massier L, Chakaroun R, Tabei S, Crane A, Didt KD, Fallmann J, von Bergen M, Haange SB, Heyne H, Stumvoll M, Gericke M, Dietrich A, Bl\u00fcher M, Musat N, Kovacs P. Adipose tissue derived bacteria are associated with inflammation in obesity and type 2 diabetes. Gut. 2020;69(10):1796\u2013806. https:\/\/doi.org\/10.1136\/gutjnl-2019-320118.","journal-title":"Gut"},{"issue":"6","key":"1496_CR118","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.2337\/db07-1403","volume":"57","author":"PD Cani","year":"2008","unstructured":"Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, Burcelin R. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes. 2008;57(6):1470\u201381. https:\/\/doi.org\/10.2337\/db07-1403.","journal-title":"Diabetes"},{"issue":"7464","key":"1496_CR119","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nature12506","volume":"500","author":"E Le Chatelier","year":"2013","unstructured":"Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, Almeida M, Arumugam M, Batto JM, Kennedy S, Leonard P, Li J, Burgdorf K, Grarup N, J\u00f8rgensen T, Brandslund I, Nielsen HB, Juncker AS, Bertalan M, Levenez F, Pons N, Rasmussen S, Sunagawa S, Tap J, Tims S, Zoetendal EG, Brunak S, Cl\u00e9ment K, Dor\u00e9 J, Kleerebezem M, Kristiansen K, Renault P, Sicheritz-Ponten T, de Vos WM, Zucker JD, Raes J, Hansen T, Bork P, Wang J, Ehrlich SD, Pedersen O, MetaHIT consortium. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013;500(7464):541\u20136. https:\/\/doi.org\/10.1038\/nature12506.","journal-title":"Nature"},{"issue":"8","key":"1496_CR120","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.3390\/cells9081909","volume":"9","author":"I Schoultz","year":"2020","unstructured":"Schoultz I, Keita \u00c5V. The intestinal barrier and current techniques for the assessment of gut permeability. Cells. 2020;9(8):1909. https:\/\/doi.org\/10.3390\/cells9081909.","journal-title":"Cells"},{"key":"1496_CR121","doi-asserted-by":"publisher","first-page":"765474","DOI":"10.3389\/fmed.2021.765474","volume":"8","author":"Z Cai","year":"2021","unstructured":"Cai Z, Wang S, Li. Treatment of inflammatory bowel disease: a comprehensive review. Front Med (Lausanne). 2021;8:765474. https:\/\/doi.org\/10.3389\/fmed.2021.765474.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"1496_CR122","doi-asserted-by":"publisher","first-page":"55","DOI":"10.14309\/ajg.0000000000002485","volume":"119","author":"S Chang","year":"2024","unstructured":"Chang S, Murphy M, Malter L. A review of available medical therapies to treat moderate-to-severe inflammatory bowel disease. Am J Gastroenterol. 2024;119(1):55\u201380. https:\/\/doi.org\/10.14309\/ajg.0000000000002485.","journal-title":"Am J Gastroenterol"},{"issue":"15","key":"1496_CR123","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.3748\/wjg.v30.i15.2068","volume":"30","author":"ZCG TriantafillidisJK","year":"2024","unstructured":"TriantafillidisJK ZCG, Konstadoulakis MM, Papalois AE. Combination treatment of inflammatory bowel disease: present status and future perspectives. World J Gastroenterol. 2024;30(15):2068\u201380. https:\/\/doi.org\/10.3748\/wjg.v30.i15.2068.","journal-title":"World J Gastroenterol"},{"key":"1496_CR124","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/628157","author":"A Michielan","year":"2015","unstructured":"Michielan A, D\u2019Inc\u00e0 R. intestinal permeability in inflammatory bowel disease: pathogenesis, clinical evaluation, and therapy of leaky gut. Mediators Inflamm. 2015. https:\/\/doi.org\/10.1155\/2015\/628157.","journal-title":"Mediators Inflamm"},{"issue":"11","key":"1496_CR125","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.3390\/diagnostics13111976","volume":"13","author":"N Perez-Diaz-Del-Campo","year":"2023","unstructured":"Perez-Diaz-Del-Campo N, Castelnuovo G, Ribaldone DG, Caviglia GP. Fecal and circulating biomarkers for the non-invasive assessment of intestinal permeability. Diagnostics (Basel). 2023;13(11):1976. https:\/\/doi.org\/10.3390\/diagnostics13111976.","journal-title":"Diagnostics (Basel)"},{"issue":"3","key":"1496_CR126","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jaci.2011.05.038","volume":"128","author":"C Xiao","year":"2011","unstructured":"Xiao C, Puddicombe SM, Field S, Haywood J, Broughton-Head V, Puxeddu I, Haitchi HM, Vernon-Wilson E, Sammut D, Bedke N, Cremin C, Sones J, Djukanovi\u0107 R, Howarth PH, Collins JE, Holgate ST, Monk P, Davies DE. Defective epithelial barrier function in asthma. J Allergy Clin Immunol. 2011;128(3):549-56.e1. https:\/\/doi.org\/10.1016\/j.jaci.2011.05.038.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"1496_CR127","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.jaci.2010.10.018","volume":"127","author":"A De Benedetto","year":"2011","unstructured":"De Benedetto A, Rafaels NM, McGirt LY, Ivanov AI, Georas SN, Cheadle C, Berger AE, Zhang K, Vidyasagar S, Yoshida T, Boguniewicz M, Hata T, Schneider LC, Hanifin JM, Gallo RL, Novak N, Weidinger S, Beaty TH, Leung DY, Barnes KC, Beck LA. Tight junction defects in patients with atopic dermatitis. J Allergy Clin Immunol. 2011;127(3):773-86.e1. https:\/\/doi.org\/10.1016\/j.jaci.2010.10.018.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"1496_CR128","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jaci.2016.03.050","volume":"139","author":"P Wawrzyniak","year":"2017","unstructured":"Wawrzyniak P, Wawrzyniak M, Wanke K, Sokolowska M, Bendelja K, R\u00fcckert B, Globinska A, Jakiela B, Kast JI, Idzko M, Akdis M, Sanak M, Akdis CA. Regulation of bronchial epithelial barrier integrity by type 2 cytokines and histone deacetylases in asthmatic patients. J Allergy Clin Immunol. 2017;139(1):93\u2013103. https:\/\/doi.org\/10.1016\/j.jaci.2016.03.050.","journal-title":"J Allergy Clin Immunol"},{"key":"1496_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.05.006","author":"T Kubo","year":"2015","unstructured":"Kubo T, Wawrzyniak P, Morita H, Sugita K, Wanke K, Kast JI, Altunbulakli C, R\u00fcckert B, Jakiela B, Sanak M, Akdis M, Akdis CA. CpG-DNA enhances the tight junction integrity of the bronchial epithelial cell barrier. J Allergy Clin Immunol. 2015. https:\/\/doi.org\/10.1016\/j.jaci.2015.05.006.","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl 2","key":"1496_CR130","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1017\/S0007114510003363","volume":"104","author":"M Roberfroid","year":"2010","unstructured":"Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I, Wolvers D, Watzl B, Szajewska H, Stahl B, Guarner F, Respondek F, Whelan K, Coxam V, Davicco MJ, L\u00e9otoing L, Wittrant Y, Delzenne NM, Cani PD, Neyrinck AM, Meheust A. Prebiotic effects: metabolic and health benefits. Br J Nutr. 2010;104(Suppl 2):S1-63. https:\/\/doi.org\/10.1017\/S0007114510003363.","journal-title":"Br J Nutr"},{"issue":"10","key":"1496_CR131","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1016\/j.jada.2006.07.010","volume":"106","author":"SJ Shepherd","year":"2006","unstructured":"Shepherd SJ, Gibson PR. Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management. J Am Diet Assoc. 2006;106(10):1631\u20139. https:\/\/doi.org\/10.1016\/j.jada.2006.07.010.","journal-title":"J Am Diet Assoc"},{"issue":"7","key":"1496_CR132","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1586\/17474124.2014.917956","volume":"8","author":"CJ Tuck","year":"2014","unstructured":"Tuck CJ, Muir JG, Barrett JS, Gibson PR. Fermentable oligosaccharides, disaccharides, monosaccharides and polyols: role in irritable bowel syndrome. Expert Rev Gastroenterol Hepatol. 2014;8(7):819\u201334. https:\/\/doi.org\/10.1586\/17474124.2014.917956.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"11","key":"1496_CR133","doi-asserted-by":"publisher","first-page":"e27961","DOI":"10.1371\/journal.pone.0027961","volume":"6","author":"Z Zakostelska","year":"2011","unstructured":"Zakostelska Z, Kverka M, Klimesova K, Rossmann P, Mrazek J, Kopecny J, Hornova M, Srutkova D, Hudcovic T, Ridl J, Tlaskalova-Hogenova H. Lysate of probiotic Lactobacillus casei DN-114 001 ameliorates colitis by strengthening the gut barrier function and changing the gut microenvironment. PLoS ONE. 2011;6(11):e27961. https:\/\/doi.org\/10.1371\/journal.pone.0027961.","journal-title":"PLoS ONE"},{"issue":"1","key":"1496_CR134","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.fbio.2013.10.002","volume":"1","author":"C Lindstr\u00f6m","year":"2012","unstructured":"Lindstr\u00f6m C, Patel A, Prajapati JB, Holst O. Probiotic properties of exopolysaccharide producing lactic acid bacteria isolated from vegetables and traditional Indian fermented foods. Int J Ferment Foods. 2012;1(1):87\u2013101. https:\/\/doi.org\/10.1016\/j.fbio.2013.10.002.","journal-title":"Int J Ferment Foods"},{"issue":"7","key":"1496_CR135","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1111\/apt.12451","volume":"38","author":"M Persborn","year":"2013","unstructured":"Persborn M, Gerritsen J, Wallon C, Carlsson A, Akkermans LM, S\u00f6derholm JD. The effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis. Aliment Pharmacol Ther. 2013;38(7):772\u201383. https:\/\/doi.org\/10.1111\/apt.12451.","journal-title":"Aliment Pharmacol Ther"},{"key":"1496_CR136","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-018-0493-6","author":"YL Tsai","year":"2019","unstructured":"Tsai YL, Lin TL, Chang CJ, Tsung-Ru W, Lai WF, Chia-Chen L, Lai HC. Probiotics, prebiotics and amelioration of diseases. J Biomed Sci. 2019. https:\/\/doi.org\/10.1186\/s12929-018-0493-6.","journal-title":"J Biomed Sci"},{"issue":"3","key":"1496_CR137","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1042\/BJ20110326","volume":"437","author":"HM Said","year":"2011","unstructured":"Said HM. Intestinal absorption of water-soluble vitamins in health and disease. Biochem J. 2011;437(3):357\u201372. https:\/\/doi.org\/10.1042\/BJ20110326.","journal-title":"Biochem J"},{"issue":"2","key":"1496_CR138","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1080\/10409238.2019.1611734","volume":"54","author":"MT Cantorna","year":"2019","unstructured":"Cantorna MT, Snyder L, Arora J. Vitamin A and vitamin D regulate the microbial complexity, barrier function, and the mucosal immune responses to ensure intestinal homeostasis. Crit Rev Biochem Mol Biol. 2019;54(2):184\u201392. https:\/\/doi.org\/10.1080\/10409238.2019.1611734.","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"2","key":"1496_CR139","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3164\/jcbn.15-148","volume":"59","author":"Z Lv","year":"2016","unstructured":"Lv Z, Wang Y, Yang T, Zhan X, Li Z, Hu H, Li T, Chen J. Vitamin A deficiency impacts the structural segregation of gut microbiota in children with persistent diarrhea. J Clin Biochem Nutr. 2016;59(2):113\u201321. https:\/\/doi.org\/10.3164\/jcbn.15-148.","journal-title":"J Clin Biochem Nutr"},{"issue":"1","key":"1496_CR140","doi-asserted-by":"publisher","first-page":"G208","DOI":"10.1152\/ajpgi.00398.2007","volume":"294","author":"J Kong","year":"2008","unstructured":"Kong J, Zhang Z, Musch MW, Ning G, Sun J, Hart J, Bissonnette M, Li YC. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am J Physiol Gastrointest Liver Physiol. 2008;294(1):G208\u201316. https:\/\/doi.org\/10.1152\/ajpgi.00398.2007.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"3","key":"1496_CR141","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1177\/2050640615572176","volume":"3","author":"T Raftery","year":"2015","unstructured":"Raftery T, Martineau AR, Greiller CL, Ghosh S, McNamara D, Bennett K, Meddings J, O\u2019Sullivan M. Effects of vitamin D supplementation on intestinal permeability, cathelicidin and disease markers in Crohn\u2019s disease: Results from a randomised double-blind placebo-controlled study. United Eur Gastroenterol J. 2015;3(3):294\u2013302. https:\/\/doi.org\/10.1177\/2050640615572176.","journal-title":"United Eur Gastroenterol J"},{"issue":"4","key":"1496_CR142","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.4049\/jimmunol.152.4.1515","volume":"152","author":"MT Cantorna","year":"1994","unstructured":"Cantorna MT, Nashold FE, Hayes CE. In vitamin A deficiency multiple mechanisms establish a regulatory T helper cell imbalance with excess Th1 and insufficient Th2 function. J Immunol. 1994;152(4):1515\u201322.","journal-title":"J Immunol"},{"issue":"3","key":"1496_CR143","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1182\/blood-2007-06-096438","volume":"111","author":"KM Elias","year":"2008","unstructured":"Elias KM, Laurence A, Davidson TS, Stephens G, Kanno Y, Shevach EM, O\u2019Shea JJ. Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3\/Stat-5 independent signaling pathway. Blood. 2008;111(3):1013\u201320. https:\/\/doi.org\/10.1182\/blood-2007-06-096438.","journal-title":"Blood"},{"issue":"6","key":"1496_CR144","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1084\/jem.20121588","volume":"210","author":"LA Mielke","year":"2013","unstructured":"Mielke LA, Jones SA, Raverdeau M, Higgs R, Stefanska A, Groom JR, Misiak A, Dungan LS, Sutton CE, Streubel G, Bracken AP, Mills KH. Retinoic acid expression associates with enhanced IL-22 production by \u03b3\u03b4 T cells and innate lymphoid cells and attenuation of intestinal inflammation. J Exp Med. 2013;210(6):1117\u201324. https:\/\/doi.org\/10.1084\/jem.20121588.","journal-title":"J Exp Med"},{"issue":"Pt 2","key":"1496_CR145","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1099\/jmm.0.017541-0","volume":"59","author":"F Van Immerseel","year":"2010","unstructured":"Van Immerseel F, Ducatelle R, De Vos M, Boon N, Van De Wiele T, Verbeke K, Rutgeerts P, Sas B, Louis P, Flint HJ. Butyric acid-producing anaerobic bacteria as a novel probiotic treatment approach for inflammatory bowel disease. J Med Microbiol. 2010;59(Pt 2):141\u20133. https:\/\/doi.org\/10.1099\/jmm.0.017541-0.","journal-title":"J Med Microbiol"},{"issue":"9","key":"1496_CR146","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.3945\/jn.109.104638","volume":"139","author":"L Peng","year":"2009","unstructured":"Peng L, Li ZR, Green RS, Holzman IR, Lin J. Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J Nutr. 2009;139(9):1619\u201325. https:\/\/doi.org\/10.3945\/jn.109.104638.","journal-title":"J Nutr"},{"key":"1496_CR147","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/B978-0-12-800100-4.00003-9","volume":"121","author":"J Tan","year":"2014","unstructured":"Tan J, McKenzie C, Potamitis M, Thorburn AN, Mackay CR, Macia L. The role of short-chain fatty acids in health and disease. Adv Immunol. 2014;121:91\u2013119. https:\/\/doi.org\/10.1016\/B978-0-12-800100-4.00003-9.","journal-title":"Adv Immunol"},{"issue":"11","key":"1496_CR148","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1002\/ibd.20543","volume":"14","author":"NA Kretzmann","year":"2008","unstructured":"Kretzmann NA, Fillmann H, Mauriz JL, Marroni CA, Marroni N, Gonz\u00e1lez-Gallego J, Tu\u00f1\u00f3n MJ. Effects of glutamine on proinflammatory gene expression and activation of nuclear factor kappa B and signal transducers and activators of transcription in TNBS-induced colitis. Inflamm Bowel Dis. 2008;14(11):1504\u201313. https:\/\/doi.org\/10.1002\/ibd.20543.","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"1496_CR149","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/s0261-5614(03)00040-2","volume":"22","author":"M Co\u00ebffier","year":"2003","unstructured":"Co\u00ebffier M, Marion R, Ducrott\u00e9 P, D\u00e9chelotte P. Modulating effect of glutamine on IL-1beta-induced cytokine production by human gut. Clin Nutr. 2003;22(4):407\u201313. https:\/\/doi.org\/10.1016\/s0261-5614(03)00040-2.","journal-title":"Clin Nutr"},{"issue":"6","key":"1496_CR150","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/pr.2012.137","volume":"72","author":"JC Chapman","year":"2012","unstructured":"Chapman JC, Liu Y, Zhu L, Rhoads JM. Arginine and citrulline protect intestinal cell monolayer tight junctions from hypoxia-induced injury in piglets. Pediatr Res. 2012;72(6):576\u201382. https:\/\/doi.org\/10.1038\/pr.2012.137.","journal-title":"Pediatr Res"},{"issue":"Suppl 1","key":"1496_CR151","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3109\/09637486.2011.627841","volume":"63","author":"M Valussi","year":"2012","unstructured":"Valussi M. Functional foods with digestion-enhancing properties. Int J Food Sci Nutr. 2012;63(Suppl 1):82\u20139. https:\/\/doi.org\/10.3109\/09637486.2011.627841.","journal-title":"Int J Food Sci Nutr"},{"issue":"2","key":"1496_CR152","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3390\/biom11020284","volume":"11","author":"J Park","year":"2021","unstructured":"Park J, Choi TJ, Kang KS, Choi SH. The interrelationships between intestinal permeability and phlegm syndrome and therapeutic potential of some medicinal herbs. Biomolecules. 2021;11(2):284. https:\/\/doi.org\/10.3390\/biom11020284.","journal-title":"Biomolecules"},{"issue":"6","key":"1496_CR153","doi-asserted-by":"publisher","first-page":"e0269698","DOI":"10.1371\/journal.pone.0269698","volume":"17","author":"S Ozaka","year":"2022","unstructured":"Ozaka S, Sonoda A, Ariki S, Minata M, Kamiyama N, Hidano S, Sachi N, Ito K, Kudo Y, Dewayani A, Chalalai T, Ozaki T, Soga Y, Fukuda C, Mizukami K, Ishizawa S, Nishiyama M, Fujitsuka N, Mogami S, Kubota K, Murakami K, Kobayashi T. Saireito, a Japanese herbal medicine, alleviates leaky gut associated with antibiotic-induced dysbiosis in mice. PLoS ONE. 2022;17(6):e0269698. https:\/\/doi.org\/10.1371\/journal.pone.0269698.","journal-title":"PLoS ONE"},{"issue":"14","key":"1496_CR154","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1080\/10408398.2015.1079165","volume":"57","author":"X Huang","year":"2017","unstructured":"Huang X, Nie S, Xie M. Interaction between gut immunity and polysaccharides. Crit Rev Food Sci Nutr. 2017;57(14):2943\u201355. https:\/\/doi.org\/10.1080\/10408398.2015.1079165.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"1496_CR155","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1021\/acsfoodscitech.2c00107","volume":"2","author":"S You","year":"2022","unstructured":"You S, Hoskin R, Komarnytsky S, Moncada M. Mushrooms as functional and nutritious food ingredients for multiple applications. ACS Food Sci Technol. 2022;2:1184\u201395. https:\/\/doi.org\/10.1021\/acsfoodscitech.2c00107.","journal-title":"ACS Food Sci Technol"},{"issue":"12","key":"1496_CR156","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1136\/gutjnl-2013-306541","volume":"63","author":"SF Clarke","year":"2014","unstructured":"Clarke SF, Murphy EF, O\u2019Sullivan O, Lucey AJ, Humphreys M, Hogan A, Hayes P, O\u2019Reilly M, Jeffery IB, Wood-Martin R, Kerins DM, Quigley E, Ross RP, O\u2019Toole PW, Molloy MG, Falvey E, Shanahan F, Cotter PD. Exercise and associated dietary extremes impact on gut microbial diversity. Gut. 2014;63(12):1913\u201320. https:\/\/doi.org\/10.1136\/gutjnl-2013-306541.","journal-title":"Gut"},{"key":"1496_CR157","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1136\/gutjnl-2016-313627","volume":"67","author":"W Barton","year":"2018","unstructured":"Barton W, Penney NC, Cronin O, Garcia-Perez I, Molloy MG, Holmes E, Shanahan F, Cotter PD, O\u2019sullivan O. The microbiome of professional athletes differs from that of more sedentary subjects in composition and particularly at the functional metabolic level. Gut. 2018;67:625\u201333. https:\/\/doi.org\/10.1136\/gutjnl-2016-313627.","journal-title":"Gut"},{"key":"1496_CR158","doi-asserted-by":"publisher","first-page":"1380713","DOI":"10.3389\/fphys.2024.1380713","volume":"15","author":"TR Dmytriv","year":"2024","unstructured":"Dmytriv TR, Storey KB, Lushchak VI. Intestinal barrier permeability: the influence of gut microbiota, nutrition, and exercise. Front Physiol. 2024;15:1380713. https:\/\/doi.org\/10.3389\/fphys.2024.1380713.","journal-title":"Front Physiol"},{"issue":"4","key":"1496_CR159","doi-asserted-by":"publisher","first-page":"G512","DOI":"10.1152\/ajpgi.00232.2020","volume":"319","author":"BH Keirns","year":"2020","unstructured":"Keirns BH, Koemel NA, Sciarrillo CM, Anderson KL, Emerson SR. Exercise and intestinal permeability: another form of exercise-induced hormesis? Am J Physiol Gastrointest Liver Physiol. 2020;319(4):G512\u20138. https:\/\/doi.org\/10.1152\/ajpgi.00232.2020.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"5","key":"1496_CR160","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/j.jaci.2019.04.027","volume":"144","author":"B Steelant","year":"2019","unstructured":"Steelant B, Wawrzyniak P, Martens K, Jonckheere AC, Pugin B, Schrijvers R, Bullens DM, Vanoirbeek JA, Krawczyk K, Dreher A, Akdis CA, Hellings PW. Blocking histone deacetylase activity as a novel target for epithelial barrier defects in patients with allergic rhinitis. J Allergy Clin Immunol. 2019;144(5):1242-1253.e7. https:\/\/doi.org\/10.1016\/j.jaci.2019.04.027.","journal-title":"J Allergy Clin Immunol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-024-01496-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-024-01496-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-024-01496-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T12:08:31Z","timestamp":1732968511000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-024-01496-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,28]]},"references-count":160,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1496"],"URL":"https:\/\/doi.org\/10.1007\/s10238-024-01496-9","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,28]]},"assertion":[{"value":"20 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"232"}}